Outpatient thyroid remnant ablation using repeated low 131-iodine activities (740 MBq/20 mCi× 2) in patients with low-risk differentiated thyroid cancer
J Clerc, M Bienvenu-Perrard… - The Journal of …, 2012 - academic.oup.com
Context: In low-risk differentiated thyroid cancer (DTC), postoperative 131I remnant ablation
should employ a minimum effective activity; reports increasingly suggest efficacy of low …
should employ a minimum effective activity; reports increasingly suggest efficacy of low …
Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or …
E Molinaro, C Giani, L Agate, A Biagini… - The Journal of …, 2013 - academic.oup.com
Background: No long-term follow-up data are available for differentiated thyroid carcinoma
(DTC) patients prepared with either exogenous or endogenous TSH and treated with low …
(DTC) patients prepared with either exogenous or endogenous TSH and treated with low …
Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk …
M Chianelli, V Todino, FM Graziano… - European Journal of …, 2009 - academic.oup.com
Objective (a) To compare the efficacy of low-activity (2 GBq; 54 mCi) 131I ablation using l-
thyroxine withdrawal or rhTSH stimulation, and (b) to assess the influence of thyroid …
thyroxine withdrawal or rhTSH stimulation, and (b) to assess the influence of thyroid …
[HTML][HTML] Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real …
A Campennì, RM Ruggeri, ML Garo, M Siracusa… - Cancers, 2023 - mdpi.com
Simple Summary The aim of the present study was to retrospectively evaluate the efficacy of
low (1.1 GBq) versus moderate (2.2 GBq) 131I activities in a large series (n= 299) of low-risk …
low (1.1 GBq) versus moderate (2.2 GBq) 131I activities in a large series (n= 299) of low-risk …
Is radioiodine ablation with 1.1 GBq (30 mCi) 131I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study
V Ilera, I Califano, A Cavallo, E Faure, A Vázquez… - Endocrine, 2023 - Springer
Background In patients with low-risk differentiated thyroid cancer (DTC), remnant ablation
with radioiodine (RA) after total thyroidectomy (TT) is controversial. No benefits have been …
with radioiodine (RA) after total thyroidectomy (TT) is controversial. No benefits have been …
Low-or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis
W Cheng, C Ma, H Fu, J Li, S Chen… - The Journal of …, 2013 - academic.oup.com
Context: There is uncertainty over the dose of 131I required for thyroid remnant ablation.
Most previous studies have been inadequately powered to establish the best fixed dose of …
Most previous studies have been inadequately powered to establish the best fixed dose of …
Effectiveness of reduced radioiodine activity for thyroid remnant ablation after total thyroidectomy in patients with low to intermediate risk differentiated thyroid …
A Todica, S Haidvogl, WP Fendler… - Nuklearmedizin …, 2017 - thieme-connect.com
Aim: To compare the success rates of radioiodine therapy (RIT) for thyroid remnant ablation
(TRA) after the administration of a high-standard activity (3700 MBq; 100 mCi) to a lower …
(TRA) after the administration of a high-standard activity (3700 MBq; 100 mCi) to a lower …
Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical 131I Therapy in Both High- and Low-Risk Patients
FA Verburg, U Mäder, C Reiners… - The Journal of Clinical …, 2014 - academic.oup.com
Context: Recent trial results have revived interest in low-activity initial 131I therapy (RIT) of
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant …
T Pilli, E Brianzoni, F Capoccetti… - The Journal of …, 2007 - academic.oup.com
Objective: Recently, a multicenter study in differentiated thyroid cancer (DTC) patients
showed that 3700 MBq 131-iodine (131I) after recombinant human TSH (rhTSH) had a …
showed that 3700 MBq 131-iodine (131I) after recombinant human TSH (rhTSH) had a …
Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer
SAR Doi, NJY Woodhouse - Clinical endocrinology, 2000 - Wiley Online Library
AIMS To compare the efficacy of remnant ablation following a single low dose (specific
activity of 131I administered, 1074–1110 MBq) vs. a single high dose (mostly 2775–3700 …
activity of 131I administered, 1074–1110 MBq) vs. a single high dose (mostly 2775–3700 …